RESEARCH-USE BIOSIMILAR ANTIBODY
Benufutamab
Monoclonal antibody · IgG1
Benufutamab (GEN1029) is a death receptor 5 (DR5)-specific agonistic antibody. Benufutamab is a mixture of 2 noncompeting DR5-specific IgG1 antibodies, each with an E430G mutation in the Fc domain. Benufutamab has antitumor effects.
TARGETTNFRSF10B
YMonoclonal antibody
CATALOGSC-BS-732
CATALOG NUMBERSC-BS-732
MOLECULAR WEIGHTApprox. 145 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Benufutamab (GEN1029) is a death receptor 5 (DR5)-specific agonistic antibody. Benufutamab is a mixture of 2 noncompeting DR5-specific IgG1 antibodies, each with an E430G mutation in the Fc domain. Benufutamab has antitumor effects.
Benufutamab is a recombinant research-use antibody directed against TNFRSF10B.